The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects
Open accessAbstract
Controlled release delivery is available for many routes of administration and offers many advantages (as microparticles and nanoparticles) over immediate release delivery. These advantages include reduced dosing frequency, better therapeutic control, fewer side effects, and, consequently, these dosage forms are well accepted by patients. Advances in polymer material science, particle engineering design, manufacture, and nanotechnology have led the way to the introduction of several marketed controlled release products and several more are in pre-clinical and clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 1×
“Besides, these copolymers are shown to be potent biological response modifiers capable of overcoming drug resistance in cancer and enhancing drug transport across cellular barriers, such as brain endothelium [63,64].”
BackgroundBatrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278 · cited 2×
“Sci. 2010, 11 3304 Poloxamers, also known by the trade name Pluronics, are nonionic triblock copolymers composed of hydrophilic poly(ethylene oxide) (PEO) and hydrophobic poly(propylene oxide) (PPO) blocks, designated as PEO-PPO-PEO [62].”
BackgroundAmphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078 · cited 1×
“For polymeric micelles, the length of the PEO blocks affects circulation time and uptake by phagocytes, with longer chains extending circulation time and reducing phagocytosis [54].”
BackgroundKim, S. Y., Shin, I. G., Lee, Y. M., Cho, C. S., & Sung, Y. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00124-7 · Cited by 330
Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.018 · Cited by 255 · cited 1×
“Chemotherapeutic agents (Figure 2) such as paclitaxel [66–68], docetaxel [69], vascular endothelial growth factor siRNA [70,71], 5-fluorourasil [72,73], doxorubicin [74,75], adriamycin [76], gancyclovir [77], celecoxib [78,79], bleomycin [80,81], and tamoxifen [29] have been successfully formulated in polymeric partic…”
Background
Cited by
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Crucho, C. I. C., & Barros, M. T. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.06.004 · Cited by 696
Recent advances in polymeric micelles for anti-cancer drug delivery
Biswas, S., Kumari, P., Lakhani, P. M., & Ghosh, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.031 · Cited by 471
Microalgae Encapsulation Systems for Food, Pharmaceutical and Cosmetics Applications
Vieira, M. V., Pastrana, L. M., & Fuciños, P. (2020) · Marine Drugs · doi:10.3390/md18120644 · Cited by 205
“Important aspects to be considered are mostly the solubility, stability, release properties, and safety; thus, for use within the food industry, the substance must have a food-grade status; and for pharmaceutical applications, it should present, among other criteria, biocompatibility and biodegradability [113].”
BackgroundSamprasit, W., Opanasopit, P., & Chamsai, B. (2021) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2021.1873370 · Cited by 50
Metadata
- Authors
- Mansour, H. M., Sohn, M., Al-Ghananeem, A., & DeLuca, P. P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2010-09-15
- Volume
- 11
- Issue
- 9
- Pages
- 3298-3322
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2160554459
- Cited by
- 215
- References
- 6
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.